Dimensional Fund Advisors LP Lyra Therapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

  • $403 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024
SELL
$0.26 - $6.25 $44,073 - $1.06 Million
-169,515 Reduced 88.76%
21,471 $6,000
Q1 2024

May 10, 2024
BUY
$4.55 - $6.53 $356,501 - $511,638
78,352 Added 69.56%
190,986 $1.19 Million
Q4 2023

Feb 07, 2024
BUY
$2.82 - $5.24 $237,951 - $442,151
84,380 Added 298.65%
112,634 $590,000
Q3 2023

Nov 09, 2023
BUY
$2.95 - $4.8 $83,349 - $135,619
28,254 New
28,254 $110,000

Others Institutions Holding LYRA

# of Institutions
61
Shares Held
32.2M
Call Options Held
21.1K
Put Options Held
400
View Full List

About Lyra Therapeutics, Inc.

LYRA Quotes by TradingView
  • Ticker LYRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,826,400
  • Market Cap $6.05M
  • Description
  • Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...
More about LYRA
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email